GRAL - GRAIL, Inc.
NEXT EARNINGS:
May 19, 2026
EPS Est: $-2.71
|
Rev Est: $38.5M
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$85.40
DETAILS
HIGH:
$130.00
LOW:
$60.00
MEDIAN:
$80.00
CONSENSUS:
$85.40
UPSIDE:
69.61%
Market Cap:
1.96B
Volume:
3,462,970
Avg Volume:
1,108,815
52 Week Range:
20.44-118.84
Sector:
Healthcare
Industry:
Medical - Diagnostics & Research
Beta:
4.55
Last Dividend:
$N/A
Exchange:
NASDAQ
Country:
US
Employees:
1,000
IPO Date:
2024-06-12
EPS (TTM):
-11.11
P/E Ratio:
-7.70
Revenue (TTM):
147.17M
Total Assets:
2.92B
Total Debt:
98.01M
Cash & Equiv:
249.73M
Rev Growth (5Y):
104.8%
EPS Growth (5Y):
N/A
FCF Growth (5Y):
N/A
ROCE:
-18.8%
Debt/Equity:
0.04
Earnings History
| Date | EPS Actual | EPS Est | EPS Surprise | Rev Actual | Rev Est | Rev Surprise |
|---|---|---|---|---|---|---|
| 2025-11-12 | $-2.46 | $-3.36 | +26.8% | $36.2M | $34.6M | +4.6% |
| 2025-08-12 | $-3.18 | $-3.14 | -1.3% | $35.5M | $34.1M | +4.2% |
| 2025-05-13 | $-3.10 | $-4.03 | +23.1% | $31.8M | $35.2M | -9.6% |
| 2025-02-20 | $-1.86 | $-4.41 | +57.8% | $38.3M | $35.8M | +6.8% |
| 2024-11-12 | $-3.94 | $-6.43 | +38.7% | $28.7M | $34.4M | -16.7% |
| 2024-08-13 | $-5.30 | — | — | $32.0M | — | — |
| 2024-03-31 | $-7.05 | — | — | $26.7M | — | — |
| 2023-12-31 | $-0.18 | — | — | $30.3M | — | — |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 147.17M | 125.59M | 93.11M | 55.55M | 14.61M | 0 | 0 | 0 |
| Net Income | (408.35M) | (2.03B) | (1.47B) | (5.40B) | (1.25B) | (312.16M) | (244.85M) | (275.72M) |
| EPS | -11.11 | -63.54 | -47.20 | -173.87 | -40.18 | -2.52 | -1.99 | -2.42 |
| Total Assets | 2.92B | 2.98B | 4.56B | 5.60B | 9.74B | 706.30M | 635.52M | 686.85M |
| Total Debt | 98.01M | 68.14M | 84.41M | 96.01M | 110.56M | 62.99M | 42.04M | 2.52M |
| Cash & Equivalents | 249.73M | 214.23M | 97.29M | 241.60M | 221.16M | 170.19M | 143.19M | 95.09M |
| Operating Cash Flow | (299.01M) | (577.16M) | (595.80M) | (561.31M) | (688.13M) | (232.00M) | (245.79M) | (209.26M) |
| Free Cash Flow | (299.01M) | (582.36M) | (608.69M) | (584.17M) | (758.06M) | (243.91M) | (249.13M) | (225.25M) |
| FCF per Share | -8.14 | -18.26 | -19.60 | -18.81 | -24.41 | -1.97 | -2.02 | -1.97 |
| Book Value | 2.58B | 2.50B | 3.65B | 4.65B | 9.43B | 561.84M | 550.53M | 600.37M |
| Cash & ST Investments | 904.43M | 763.47M | 97.29M | 241.60M | 221.16M | 583.48M | 544.34M | 641.35M |
| ROC Equity | -0.16 | -0.81 | -0.40 | -1.16 | -0.13 | -0.56 | -0.44 | -0.46 |